Skip to content

Study on postprandial blood glucose response test food intake in healthy subjects.

Study on postprandial blood glucose response test food intake in healthy subjects. - Study on postprandial blood glucose response test food intake in healthy subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052434
Enrollment
15
Registered
2023-10-10
Start date
2023-10-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults

Interventions

Sponsors

CXwellness Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Adult men between the ages of 20 and under 75 2. Subjects belonging to Kewpie Co. or medical institution who wish to voluntarily participate in clinical trials and obtain written consent. 3. Subjects who can maintain their daily habits during the test per

Exclusion criteria

Exclusion criteria: 1. Are diagnosed with serious illness (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental illness. 2. Have a history of serious illness. (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) 3. Have donated more than 200 mL of blood within one month or more than 400 mL of blood within three months before the start of the study. 4. Have experience of worsening physical condition due to blood sampling, or have been pointed out the blood sampling difficulty due to narrow blood vessels. 5. Have serious anemia 6. Have large changes in diet and exercise and cannot maintain their daily lifestyle. 7. Allergies to any medications or test foods 8. Taking foods or dietary supplements with functional health claims regularly 9. Unsuitable for the study, as determined by the investigator.

Design outcomes

Primary

MeasureTime frame
Blood glucose and insulin level

Secondary

MeasureTime frame
Blood triglyceride, GLP-1, and GIP level

Countries

Japan

Contacts

Public ContactTatsuo Uetake

CXwellness, Inc. Representative director

uetake@cx-wellness.com03-6225-5601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026